Pharma business info

The pharmaceutical business has lifted up fears over parts of US President US President Barack Obama’s fiscal 2013 financial plan, claiming that the proposals could resulted in considerable job losses in the division.

Drug maufacturer GlaxoSmithKline Pharmaceuticals stated that the continued expansion of specialty products and vaccines, novel product launches and taut expense control assisted perk up profits.

Scrip of Sun Pharmaceutical Industries on Feb 16 declined around 3%, as the company stated that that US-based Wyeth Pharmaceuticals has sought compensation worth $960 million in a patent clash.

DARA BioSciences has entered into an exclusive United States deal with Uman Pharma for commercial rights to gemcitabine, an anticancer agent.